IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens

RV144 correlates of risk analysis showed that IgG antibodies to gp70V1V2 scaffolds inversely correlated with risk of HIV acquisition. We investigated IgG antibody responses in RV135 and RV132, two ALVAC-HIV prime-boost vaccine trials conducted in Thailand prior to RV144. Both trials used ALVAC-HIV (...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:AIDS Res Hum Retroviruses
المؤلفون الرئيسيون: Karasavvas, Nicos, Karnasuta, Chitraporn, Savadsuk, Hathairat, Madnote, Sirinan, Inthawong, Dutsadee, Chantakulkij, Somsak, Rittiroongrad, Surawach, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Thongcharoen, Prasert, Siriyanon, Vinai, Andrews, Charla A., Barnett, Susan W., Tartaglia, James, Sinangil, Faruk, Francis, Donald P., Robb, Merlin L., Michael, Nelson L., Ngauy, Viseth, de Souza, Mark S., Paris, Robert M., Excler, Jean-Louis, Kim, Jerome H., O'Connell, Robert J.
التنسيق: Artigo
اللغة:Inglês
منشور في: Mary Ann Liebert, Inc. 2015
الموضوعات:
Vaccines
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4651018/
https://ncbi.nlm.nih.gov/pubmed/26234467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2015.0034
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة